MangoRx vs Noom
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
MangoRx
Best for pending product verificationStarting at $199/mo
Side-by-Side Comparison
| Feature | MangoRx | Noom |
|---|---|---|
| Overall Score | 7.1/10 | 7.1/10 |
| Starting Price | $199/mo | — |
| Editorial Rating | 3.6 ★ /5 | 3.6 ★ /5 |
| Features | ✓3 features | 2 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
MangoRx
Pros
- ✓Katalys-approved program at 14% commission — attractive on higher AOV orders
- ✓Men's-health-focused telehealth — bundled GLP-1 + TRT + ED + hair lets a single user fill multiple needs through one provider
Cons
- ✗Stub entry — exact GLP-1 drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
- ✗Cross-selling TRT alongside GLP-1s is editorially worth disclosing — readers looking specifically for weight loss may not want to be funneled into a men's-hormone broader program
Noom
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Pricing not publicly disclosed
Our Verdict
Both MangoRx and Noom score equally well overall — the right choice depends on your priorities. Choose MangoRx if you want pending product verification, or Noom if mainstream telehealth GLP-1 access matters most to you.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.